V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210002894 | 210010288 | 1.59 | 77.6 | Disease modification (D) | null | 2018-02-20 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 101100211 |
| 210002898 | 210010290 | 1.67 | null | Adjuvant (A) | 2019-01-08 | 2019-01-30 | Paclitaxel 7 day | null | N | PACLITAXEL | 100974758 |
| 210002899 | 210010291 | 1.7 | 72.3 | Neo-adjuvant (N) | null | 2020-07-20 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101464667 |
| 210002904 | 210010292 | null | 105 | null | 2015-01-07 | 2017-07-26 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 100036885 |
| 210002905 | 210010293 | 1.79 | 48.6 | Adjuvant (A) | 2019-12-12 | 2019-12-14 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 101028049 |
| 210002906 | 210010294 | 1.66 | 84.3 | null | null | 2018-09-15 | Paclitaxel 7 day | null | N | PACLITAXEL | 100885329 |
| 210002908 | 210010295 | 1.68 | 84.7 | null | null | 2018-08-21 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100285598 |
| 210002910 | 210010296 | 1.53 | null | Adjuvant (A) | 2018-11-03 | 2018-11-24 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100774139 |
| 210002912 | 210010298 | 1.62 | 105.7 | Adjuvant (A) | 2019-03-15 | 2019-06-30 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101686428 |
| 210002917 | 210010301 | null | 73.2 | Adjuvant (A) | 2018-05-26 | 2018-05-31 | Docetaxel | null | N | DOCETAXEL | 101308691 |
| 210002920 | 210010302 | null | 77.5 | null | 2018-02-12 | 2018-06-25 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 101155828 |
| 210002922 | 210010304 | 1.52 | 86.7 | Adjuvant (A) | null | 2018-03-10 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 100940930 |
| 210002924 | 210010305 | null | 83.4 | null | null | 2017-06-08 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 101550346 |
| 210002925 | 210010306 | 1.56 | null | Adjuvant (A) | 2022-05-05 | 2022-05-10 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 101151301 |
| 210002926 | 210010307 | 1.58 | 75.4 | Palliative (P) | null | 2016-09-06 | Paclitaxel 7 day | null | N | PACLITAXEL | 101170018 |
| 210002929 | 210010309 | null | 75.5 | null | null | 2021-03-05 | Trastuzumab | 02 | null | TRASTUZUMAB | 100868610 |
| 210002930 | 210010310 | 1.63 | null | Palliative (P) | 2018-08-17 | 2018-12-04 | Trastuzumab | 02 | null | TRASTUZUMAB | 100581865 |
| 210002931 | 210010311 | 1.58 | 100.1 | Palliative (P) | 2018-08-27 | 2018-12-09 | Trastuzumab Subcutaneous | null | null | TRASTUZUMAB | 101273592 |
| 210002935 | 210010313 | 1.57 | 83.6 | Palliative (P) | 2018-11-11 | 2019-01-21 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100668526 |
| 210002939 | 210010315 | 1.53 | 71.4 | Adjuvant (A) | 2017-09-15 | 2017-12-10 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101686502 |
| 210002941 | 210010316 | 1.76 | null | Adjuvant (A) | 2017-05-16 | 2017-05-16 | PACLITAXEL | N | N | PACLITAXEL | 100371653 |
| 210002943 | 210010317 | null | 77 | null | null | 2021-09-07 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | PACLITAXEL | 100086843 |
| 210002951 | 210010318 | 1.71 | 71.5 | null | 2017-09-22 | 2017-10-02 | EC | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100080202 |
| 210002956 | 210010319 | 0 | 64.1 | null | null | 2017-02-15 | Docetaxel | 02 | null | DOCETAXEL | 100256975 |
| 210002957 | 210010320 | 1.5 | 70 | Adjuvant (A) | null | 2016-09-03 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 101563075 |
| 210002961 | 210010322 | 1.63 | 63.6 | Palliative (P) | 2016-09-27 | 2017-08-06 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100315730 |
| 210002962 | 210010323 | 1.72 | 69.7 | Palliative (P) | 2017-12-01 | 2017-12-28 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100080286 |
| 210002966 | 210010324 | 1.68 | 85.5 | Palliative (P) | 2017-09-30 | 2017-12-11 | Paclitaxel 80mg/m2 day 1 8 15 | null | N | PACLITAXEL | 101746239 |
| 210002971 | 210010325 | 1.5 | 69.3 | Adjuvant (A) | 2017-04-28 | 2017-04-28 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101127094 |
| 210002976 | 210010326 | 1.67 | 88.8 | null | null | 2019-03-13 | Trastuzumab | 02 | null | TRASTUZUMAB | 100655685 |
| 210002982 | 210010329 | 1.7 | 57.9 | null | null | 2017-10-20 | Docetaxel | N | null | DOCETAXEL | 101036882 |
| 210002983 | 210010330 | 1.75 | 81.7 | Adjuvant (A) | null | 2020-01-28 | Trastuzumab | null | N | TRASTUZUMAB | 100403952 |
| 210002984 | 210010331 | null | null | null | 2019-06-28 | 2019-10-18 | EC | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101104877 |
| 210002986 | 210010333 | 1.58 | 68 | Adjuvant (A) | null | 2021-08-08 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101683041 |
| 210002989 | 210010334 | 1.47 | 82 | null | null | 2019-08-08 | Docetaxel | 02 | null | DOCETAXEL | 100530225 |
| 210002992 | 210010336 | 1.54 | 83 | Palliative (P) | null | 2019-04-05 | Docetaxel | 02 | N | DOCETAXEL | 101079367 |
| 210002995 | 210010338 | null | null | null | 2018-08-04 | 2018-09-02 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 101832415 |
| 210002996 | 210010339 | 1.58 | 75.9 | Adjuvant (A) | 2021-07-10 | 2021-10-19 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101527764 |
| 210002998 | 210010340 | 1.56 | 80.4 | null | 2020-08-30 | 2020-08-30 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101435951 |
| 210003001 | 210010343 | null | null | Curative (C) | null | 2020-07-22 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 100250389 |
| 210003002 | 210010344 | 1.61 | 71.85 | Adjuvant (A) | 2016-07-09 | 2019-08-23 | PACLITAXEL | null | N | PACLITAXEL | 100825509 |
| 210003005 | 210010345 | null | 75.75 | Adjuvant (A) | null | 2017-01-16 | Docetaxel 100mg/m2 (21 day) | null | N | DOCETAXEL | 100943216 |
| 210003006 | 210010346 | 1.73 | 71.85 | null | null | 2019-01-02 | PACLITAXEL | 02 | null | PACLITAXEL | 100469150 |
| 210003014 | 210010350 | 1.49 | 47.5 | null | 2018-09-30 | 2018-10-07 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 100010373 |
| 210003019 | 210010352 | 1.64 | 70.7 | Adjuvant (A) | 2017-03-06 | 2017-03-13 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101165207 |
| 210003027 | 210010354 | null | null | null | 2020-10-31 | 2020-11-13 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | PACLITAXEL | 101389681 |
| 210003028 | 210010355 | 1.65 | 0 | Palliative (P) | 2017-04-22 | 2017-07-21 | Docetaxel | null | N | DOCETAXEL | 101552841 |
| 210003029 | 210010356 | 0 | 88.9 | Adjuvant (A) | 2019-06-22 | 2019-09-13 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100927096 |
| 210003031 | 210010358 | 1.74 | 52.4 | Adjuvant (A) | null | 2017-04-26 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100220188 |
| 210003034 | 210010359 | null | 87.9 | Adjuvant (A) | 2019-11-01 | 2019-11-11 | Docetaxel 100mg/m2 (21 day) | 02 | null | DOCETAXEL | 101051849 |